| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.984 | 0.001 | 0.984 | Androgen antagonist | 0.407 0.005 DBMET00741 | ||
| 0.954 | 0.001 | 0.954 | Diuretic | 0.881 0.002 DBMET00741 | ||
| 0.923 | 0 | 0.923 | Aldosterone antagonist | 0.539 0.001 DBMET00741 | ||
| 0.88 | 0.001 | 0.88 | Mineralocorticoid receptor antagonist | 0.837 0.001 DBMET00741 | ||
| 0.878 | 0.001 | 0.878 | Progesterone antagonist | 0.234 0.004 DBMET00741 | ||
| 0.854 | 0.001 | 0.854 | Androgen agonist | 0.222 0.004 DBMET00741 | ||
| 0.852 | 0.01 | 0.852 | Apoptosis agonist | 0.593 0.05 DBMET00741 | ||
| 0.75 | 0.001 | 0.75 | Progesterone agonist | 0.387 0.001 DBMET00741 | ||
| 0.721 | 0.002 | 0.721 | Aromatase inhibitor | 0.148 0.013 DBMET00741 | ||
| 0.712 | 0.019 | 0.712 | Transcription factor NF kappa B inhibitor | 0.291 0.099 DBMET00741 | ||
| 0.708 | 0.029 | 0.796 | Antiinflammatory | 0.796 0.016 DBMET00741 | DBMET00741 | |
| 0.628 | 0.002 | 0.628 | Lipocortins synthesis antagonist | 0.515 0.004 DBMET00741 | ||
| 0.592 | 0.01 | 0.592 | Nitric oxide antagonist | 0.428 0.022 DBMET00741 | ||
| 0.557 | 0.01 | 0.663 | Cardiotonic | 0.663 0.005 DBMET00741 | DBMET00741 | |
| 0.539 | 0.011 | 0.539 | Hypoxia-inducible factor 1 alpha inhibitor | 0.207 0.144 DBMET00741 | ||
| 0.465 | 0.006 | 0.483 | Sodium/bile acid cotransporter inhibitor | 0.483 0.004 DBMET00741 | DBMET00741 | |
| 0.491 | 0.063 | 0.491 | Caspase 9 stimulant | |||
| 0.428 | 0.006 | 0.428 | Interleukin 6 antagonist | 0.248 0.023 DBMET00741 | ||
| 0.423 | 0.001 | 0.423 | 5-Alpha-reductase 1 inhibitor | 0.03 0.009 DBMET00741 | ||
| 0.41 | 0.003 | 0.41 | Estradiol 17 beta-dehydrogenase inhibitor | 0.105 0.01 DBMET00741 | ||
| 0.388 | 0.002 | 0.388 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.043 0.014 DBMET00741 | ||
| 0.381 | 0.002 | 0.381 | 5-Alpha-reductase inhibitor | 0.189 0.005 DBMET00741 | ||
| 0.413 | 0.035 | 0.413 | Apoptosis antagonist | 0.273 0.105 DBMET00741 | ||
| 0.425 | 0.054 | 0.425 | Immunosuppressant | 0.331 0.097 DBMET00741 | ||
| 0.374 | 0.012 | 0.374 | Interferon gamma antagonist | |||
| 0.401 | 0.049 | 0.537 | Antithrombotic | 0.537 0.024 DBMET00741 | DBMET00741 | |
| 0.352 | 0.002 | 0.352 | 5-Alpha-reductase 2 inhibitor | |||
| 0.337 | 0.017 | 0.337 | Melanin inhibitor | |||
| 0.375 | 0.056 | 0.375 | Cholesterol antagonist | 0.197 0.167 DBMET00741 | ||
| 0.295 | 0.003 | 0.295 | Glucocorticoid antagonist | 0.093 0.005 DBMET00741 | ||
| 0.292 | 0.002 | 0.292 | Arachidonic acid antagonist | 0.284 0.003 DBMET00741 | ||
| 0.288 | 0.005 | 0.288 | Estrogen agonist | 0.151 0.011 DBMET00741 | ||
| 0.291 | 0.012 | 0.291 | Cholesterol synthesis inhibitor | 0.217 0.023 DBMET00741 | ||
| 0.283 | 0.007 | 0.283 | Estrogen antagonist | 0.133 0.035 DBMET00741 | ||
| 0.267 | 0.002 | 0.267 | RNA-directed RNA polymerase stimulant | 0.134 0.004 DBMET00741 | ||
| 0.319 | 0.061 | 0.319 | Interleukin 2 agonist | |||
| 0.26 | 0.006 | 0.26 | Hedgehog signaling inhibitor | |||
| 0.275 | 0.034 | 0.275 | P-glycoprotein inhibitor | |||
| 0.237 | 0.012 | 0.237 | Microtubule formation inhibitor | 0.169 0.029 DBMET00741 | ||
| 0.274 | 0.068 | 0.274 | DNA damaging | |||
| 0.234 | 0.03 | 0.234 | NOS3 expression enhancer | |||
| 0.242 | 0.043 | 0.242 | Neurotrophic factor enhancer | |||
| 0.202 | 0.004 | 0.202 | Anabolic | 0.142 0.023 DBMET00741 | ||
| 0.248 | 0.051 | 0.248 | Anesthetic general | |||
| 0.191 | 0.005 | 0.191 | Estrogen receptor beta agonist | 0.11 0.01 DBMET00741 | ||
| 0.204 | 0.027 | 0.204 | DNA polymerase I inhibitor | 0.157 0.046 DBMET00741 | ||
| 0.268 | 0.098 | 0.268 | Caspase 3 stimulant | |||
| 0.237 | 0.074 | 0.444 | Hypolipemic | 0.444 0.018 DBMET00741 | DBMET00741 | |
| 0.163 | 0.003 | 0.163 | Estrone sulfatase inhibitor | 0.079 0.005 DBMET00741 | ||
| 0.166 | 0.01 | 0.166 | Estrogen receptor alpha antagonist | |||
| 0.158 | 0.005 | 0.158 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.144 0.005 DBMET00741 | ||
| 0.211 | 0.059 | 0.211 | Hepatoprotectant | 0.171 0.088 DBMET00741 | ||
| 0.193 | 0.044 | 0.193 | Protein kinase stimulant | |||
| 0.153 | 0.005 | 0.153 | Na+ K+ transporting ATPase inhibitor | 0.147 0.006 DBMET00741 | ||
| 0.145 | 0.008 | 0.145 | Glycine receptor antagonist | 0.078 0.061 DBMET00741 | ||
| 0.133 | 0.006 | 0.133 | Estrogen receptor alpha agonist | 0.071 0.013 DBMET00741 | ||
| 0.152 | 0.027 | 0.152 | Antineoplastic alkaloid | |||
| 0.124 | 0.003 | 0.13 | Lipocortins synthesis agonist | 0.13 0.002 DBMET00741 | DBMET00741 | |
| 0.274 | 0.155 | 0.466 | Antibacterial | 0.466 0.051 DBMET00741 | DBMET00741 | |
| 0.138 | 0.019 | 0.138 | Estrogen receptor beta antagonist | 0.096 0.072 DBMET00741 | ||
| 0.153 | 0.049 | 0.153 | Farnesoid X receptor antagonist | 0.119 0.105 DBMET00741 | ||
| 0.15 | 0.052 | 0.15 | Pregnane X receptor agonist | |||
| 0.206 | 0.11 | 0.206 | Antioxidant | |||
| 0.104 | 0.011 | 0.104 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.042 0.038 DBMET00741 | ||
| 0.118 | 0.039 | 0.118 | Antineoplastic antibiotic | |||
| 0.183 | 0.114 | 0.183 | Aldehyde oxidase inhibitor | |||
| 0.1 | 0.035 | 0.1 | Opioid kappa receptor antagonist | |||
| 0.079 | 0.015 | 0.079 | Heme oxygenase stimulant | 0.06 0.046 DBMET00741 | ||
| 0.066 | 0.005 | 0.066 | Glucose-6-phosphate dehydrogenase inhibitor | 0.052 0.01 DBMET00741 | ||
| 0.06 | 0.004 | 0.06 | Glucocorticoid agonist | 0.054 0.004 DBMET00741 | ||
| 0.167 | 0.112 | 0.167 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.06 | 0.005 | 0.06 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.085 | 0.032 | 0.085 | Glycine receptor agonist | |||
| 0.066 | 0.016 | 0.066 | Vanilloid 2 antagonist | 0.061 0.022 DBMET00741 | ||
| 0.06 | 0.014 | 0.06 | Microtubule stabilization | 0.052 0.025 DBMET00741 | ||
| 0.045 | 0.004 | 0.045 | Corticosteroid-like | 0.022 0.014 DBMET00741 | ||
| 0.045 | 0.011 | 0.045 | Tubulin agonist | 0.035 0.021 DBMET00741 | ||
| 0.044 | 0.01 | 0.044 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.061 | 0.029 | 0.061 | Pregnane X receptor antagonist | |||
| 0.08 | 0.049 | 0.08 | Keratolytic | |||
| 0.246 | 0.218 | 0.477 | Cyclophilin D inhibitor | 0.477 0.057 DBMET00741 | DBMET00741 | |
| 0.083 | 0.057 | 0.083 | Inducible nitric-oxide synthase inhibitor | |||
| 0.025 | 0.002 | 0.025 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.007 DBMET00741 | ||
| 0.164 | 0.143 | 0.164 | Immunostimulant | |||
| 0.116 | 0.098 | 0.116 | Lipid peroxidase inhibitor | |||
| 0.037 | 0.019 | 0.051 | HMG CoA reductase inhibitor | 0.051 0.007 DBMET00741 | DBMET00741 | |
| 0.054 | 0.036 | 0.054 | Protein 50S ribosomal subunit inhibitor | |||
| 0.096 | 0.079 | 0.096 | Monophenol monooxygenase inhibitor | |||
| 0.142 | 0.129 | 0.142 | Antimitotic | |||
| 0.036 | 0.024 | 0.036 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.026 | 0.019 | 0.026 | Toll-Like receptor 4 agonist | |||
| 0.084 | 0.078 | 0.084 | ABCA1 expression enhancer | |||
| 0.008 | 0.003 | 0.008 | Transcortin receptor antagonist | |||
| 0.181 | 0.177 | 0.2 | Gastrin inhibitor | 0.2 0.15 DBMET00741 | DBMET00741 | |
| 0.016 | 0.015 | 0.016 | Telomerase stimulant | |||
| 0.134 | 0.144 | 0.141 | Phospholipase C inhibitor | 0.141 0.127 DBMET00741 | DBMET00741 | |
| 0.083 | 0.099 | 0.127 | Protein-tyrosine phosphatase 1B inhibitor | 0.127 0.058 DBMET00741 | DBMET00741 | |
| 0.055 | 0.094 | 0.128 | CDC25A inhibitor | 0.128 0.017 DBMET00741 | DBMET00741 | |
| 0.025 | 0.146 | 0.059 | Phosphofructokinase-1 inhibitor | 0.059 0.058 DBMET00741 | DBMET00741 | |
| 0.07 | 0.213 | 0.205 | Protein-tyrosine phosphatase inhibitor | 0.205 0.045 DBMET00741 | DBMET00741 | |
| 0.07 | 0.298 | 0.134 | Hemostatic | 0.134 0.089 DBMET00741 | DBMET00741 | |
| 0.021 | 0.415 | 0.15 | GABA C receptor antagonist | 0.15 0.03 DBMET00741 | DBMET00741 | |
| 0.007 | 0.424 | 0.165 | HIV-1 integrase (Strand Transfer) inhibitor | 0.165 0.012 DBMET00741 | DBMET00741 | |
| 0.005 | 0.563 | 0.169 | HIV-1 integrase (3'-Processing) inhibitor | 0.169 0.012 DBMET00741 | DBMET00741 | |
| 0.002 | 0.736 | 0.023 | Purinergic P2X agonist | 0.023 0.022 DBMET00741 | DBMET00741 | |
| 0.014 | 0.747 | 0.093 | Thioredoxin inhibitor | 0.093 0.057 DBMET00741 | DBMET00741 | |
| 0.004 | 0.941 | 0.186 | Dual specificity phosphatase 3 inhibitor | 0.186 0.069 DBMET00741 | DBMET00741 | |
| 0.005 | 0.952 | 0.178 | Dual specificity phosphatase inhibitor | 0.178 0.069 DBMET00741 | DBMET00741 | |
| 0.004 | 0.978 | 0.066 | Purinergic P2Y2 antagonist | 0.066 0.007 DBMET00741 | DBMET00741 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |